• A new type of antithrombotic effect of monamine oxidase (MAO) inhibitors which prevented the formation of intravaseular thrombosis without inhibition of extravascular clotting was observed by the authors. 1 " 3 It was considered that MAO inhibitor blocks the phylogenetically old hemostatic process played by platelets 4 ' B and leucocytes but not directly the phylogenetically young flbrinogen fibrin system.
In the experiments reported below, experimental thrombosis was produced by traumatization of vascular endothelium in normal, sympathectomized, and denervated arteries and veins of the ears of rabbits. Prevention of thrombosis by nialamide, a MAO inhibitor, was compared with that of two prothrombinopenic anticoagulants, phenindione and warfarin.
Methods The endothelial surface of the retroauricular artery and marginal vein of the ears of 157 male rabbits (weig-hing 1.7 to 2.8 Kg., mean 2.2 ± 0.4 Kg.) was traumatized by a dental hand reamer. The reamer was inserted into the vessel lumen to a depth of 3 em. The reamer, together with the blood vessels and surrounding tissues, was held and pressed together by a special holder. Then the reamer was pulled out to traumatize the endothelial surface of the blood vessels. A no. 6 dental hand reamer was used for the artei-y, and a no. 8 dental hand reamer for the vein. The same holder with a spring and the same dental hand reamer produced almost a similar traumatization in each case. This dental hand reamer and crushing method used in this experiment are superior to the classic thread and crushing method, 2 From the Department of Clinical Physiology and Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
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Circulation Research, Volume X, April 1962 because with the new method only one place in the vessel wall is penetrated by the reamer instead of two places by the classic method. Thus, damage to the vessel wall is minimized by the new method as compared with the classic method.
PREVENTION TESTS
In the first series of experiments, 36 animals were divided into three equal croups: the control, nialamide,* and the phenindionet groups. The animals of the nialamide croup received 5 mc./Kc. of nialamide two hours before traumatization of the blood vessels. The animals of the phenindione group received 400 mg. of phenindione 24 hours before, and 200 mg. immediately before the challenge. Thus, the antithrombotic effect of 5 m£r./K\<r. of ninlnmide was compared with GOO mg. of phenindione, the evaluation of results being performed 24 hours after traumatization.
In the second series of exueriments, 20 rabbits were divided into four equal crouns: the control, Dhenindione. nialnmidp. and the nialamide-phenindione grout>s. The animals of the phenindione and the nialamide-nhenindione croups received 400 me. of phenindione 24 hours before, and 200 m<r. immediately before the challenge, and 100 mar. everv 24 hours after the challenge for three dnvs. The animals of the nialamide and the nialamide-phenindione groups received 5 mc./rtc. of nialamide two hours before the challenge and every 24 hours thereafter for five days. The evaluation of the results was performed five days, instead of 24 hours, after traumatization of the blood vessels.
In the third series of experiments, 15 animals were divided into four groups: the control, phenindione, nialamide, and the nialamide-nhenindione groups. The animals of the nialamide and the nialamide-phenindione groups received 5 mg./Kg. of nialamide two hours before the challenge, as in the first series of experiments, but the animals of the phenindione and the ninlnmidp-phonindione groups received 200 mg. of phenindione 24 hours before, and 100 mg. immediatelv h°fore traumatization, so that a single dose of phenindione was *Nialamide was supplied through the courtesy of Charles Pfizer & Company, Inc.
tPhenindione was supplied through the courtesy of the Daiichi Pharmaceutical Company. reduced by half as compared with the first series of experiments. The evaluation of the result was performed 24 hours after the challenge.
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In the fourth series of experiments, nine animals were divided into three equal groups: the control, phenindione, and nialamide groups. The animals of the nialamide group received 3 mg./Kg. of nialamide and the animals of the phenindione group received 100 mg. of phenindione 24 hours before, and 50 mg. immediately before the challenge, the evaluation of the results being performed 24 hours after the challenge.
In the fifth series of experiments, 30 animals were divided into four groups: the control, phenindione, nialamide, and two nialamide-phenindione groups. The animals of the nialamide and the nialamide-phenindione groups received 1.5 mg./ Kg. of nialamide. The animals of the phenindione group and the nialamide-phenindione group received 100 mg. of phenindione 24 hours before, and 50 mg. immediately before the challenge. The evaluation was performed 24 hours aiter the challenge.
In the sixth series of experiments, 11 animals were divided into four groups: three were controls. In the fourth warfarin* was administered to eight animals: 1 mg./Kg. to three; 3 mg./Kg. to three; and 5 mg./Kg. to two animals for three days. Directly after the last administration, the challenge was performed. The evaluation of the results was performed 24 hours thereafter.
EXPERIMENT IN THE SYMPATHECTOMIZED ANIMALS AND DENERVATED BLOOD VESSELS
For the purpose of observing the influence of vasomotor innervation on the effects of nialamide, the superior cervical sympathetic ganglion was extirpated on one side in all 20 animals of the *The warfarin used was produced by S. B. Penick & Company. seventh series of experiments and the challenge was performed at the same time. Ten animals were controls and 10 animals were pretreated by 5 mg./Kg. of nialamide two hours before the challenge. The evaluation of the result was performed 24 hours after the challenge.
In the eighth series of experiments performed on 16 animals, under light anesthesia., the superior cervical sympathetic ganglion was extirpated on one side and n. retroauricularis and n. aurieularis magnus were transected on the same side at the site before they enter the ear. After recovery from anesthesia, it was ascertained that the response of animals to painful stimuli given locally to the ear had been completely abolished by this procedure. Thus the retroaurieular artery and marginal vein were denervated on one side and these denervated blood vessels were subjected to the challenge two weeks after the denervation. The evaluation of the results was performed 24 hours thereafter.
DETERMINATION OF PROTHROMBIN ACTIVITY
Using thrombokinase (Geigy) with calcium, the one-stage prothrombin time was measured according to Quick's modified method 0 and was plotted against the prothrombin concentration of plasma. The values of pi'othrombin time in concentration of normal for rabbit plasma are presented in table 1.
The prothrombin time was measured immediatety before the challenge, the blood being drawn from the femoral vein and, at the end of the experiment, the blood being drawn from the heart by cardiac puncture with a silicone-coated syringe and needle.
The evaluation of morphological changes of blood vessels traumatized was performed grossly one, two, or five days after trauinatization. For the purpose of ascertaining the occlusion by thrombosis, physiological saline was injected into the vessel lumen as a final gross observation. After the final evaluation by gross observation, the blood vessels were removed surgically and fixed in 1.0 per cent formalin for histochemical demonstration using serial sections. The blind technique was utilized fully in our examination, including the evaluation of results.
Oral administration was performed by nse of a gelatin capsule containing nialamide or phenindione. The rabbits easily swallowed the capsules when they were gently passed through the throat with a pincette.
Results
In the coiitrol animal, the thrombus was formed and grossly visible a few hours after traumatization. Twentv-four hours after Comparison of vascular thrombosis in five groups. Occlusive thrombi (black); patent (oblique line); no macroscopic or microscopic thrombi (blank). The number written inside each figure represents the number of blood vessels involved. The number written outside each figure represents the percentage of blood vessels involved. The same notation holds for figures 2 through 5.
trauinatization, occlusive thrombosis was almost fully developed; 48 hours after traumatization, the thrombus showed little further growth ; five clays later, a slight regression was observed.
The data obtained in the first, second, third, fourth, fifth, and sixth series of experiments were summarized in figures 1, 2, and 3, because no principal difference was found in the results in each series of experiments. However, the duration of treatment, the dose of drugs, and the time distance from the challenge to the final evaluation were different in each series of experiments, as detailed in the paragraph for the method.
As shown in figure 1 , occlusive thrombosis, as well as grossly visible thrombosis including occlusive thrombosis in the artery and vein, is significantly reduced in animals treated with 3 to 5 mg./Kg. of nialamide (Z 1 < 0.001) as compared with the control animals.
The appearance of occlusive thrombosis in the artery and vein of animals treated with 300 to 900 mg. of phenindione is also significantly reduced as compared with the control animals (P < 0.01). The appearance of grossly visible thrombosis as a whole is not reduced, although the prothrombin activity of the blood of these animals was severely reduced (the mean value was 10.8 per cent ± 3.6). This data shows a clear-cut antithrombotic effect of 3 to 5 mg./Kg. of nialamide, which is larger than that of 300 to 900 mg. of phenindione. In the animals treated with 3 to 5 mg./Kg. of nialamide, plus 300 to 900 ing. of phenindione, the appearance of occlu- Comparison of vascular thrombosis in four groups. sive as well as grossly visible thrombosis is reduced significantly as compared with the control animals. However, it is not significantly smaller as compared with the animals treated with 3 to 5 mg. of nialamide alone, although there is a significant reduction in the prothrombin activity of the blood in this group treated with both substances concomitantly (mean value 12.6 per cent ± 4.6).
In the animals treated with large amount of warfarin, the appearance of grossly visible thrombosis as well as occlusive thrombosis is reduced as compared with the control animals, but significantly larger as compared with the animals treated with nialamide. The number of animals treated with warfarin is too small, and the preventive effect of such a large amount of warfarin was statistically insignificant although the prothrombin activity of the blood was severely reduced (mean value 12.5 per cent ± 10.8).
Pretreatment with 5 mg./Kg. of nialamide seems more effective than 3 mg./Kg. Occlusive thrombosis appeared in 3 of 12 traumatized vessels in the animals pretreated with 3 mg./Kg., while only 9 of a total of 80 traumatized vessels showed occlusive thrombosis when the animals Avere pretreated with 5 mg./Kg. of nialamide. This difference, IIOAVever, is not statistically significant. Figure 2 shows that, the animals treated with. 1.5 mg./Kg. of nialamide or treated with 150 mg. of phenindione exhibited no significant reduction in the appearance of ocelusive Control Artery Vein Nialamide 5 m g,'. Artery Vein
FIGURE 3
Comparison of vascular thrombi of denervated blood vessels in control and nialamide f/roups. as well as grossly visible thrombosis, although the animals treated with phenindione exhibited a reduction in the prothrombin activity of the blood (mean value 11.5 per cent ± 4.9). However, the animals treated with 1.5 mg./ Kg. of nialamide, plus 150 mg. of phenindione, exhibited a significant reduction in the appearance of occlusive thrombosis in the artery (P < 0.001) as compared with the control animals, although the reduction in the prothrombin activity in this group is almost the same as compared with that of animals treated with 150 mg. phenindione alone.
In all series of experiments, including the following last two series, the difference in the appearance of thrombosis between the artery and the vein was insignificant, as shown in the figures 1 and 2, except for two groups with a small number of animals treated with 150 mg. phenindione and 1.5 mg./Kg. nialamide. Here the preventive effect was somewhat larger in the artery than in the vein. Figure 3 illustrates that the preventive effect was larger in the vein than in the artery in Circulation Research, Volume X, April 196S denervated animals treated with 5 mg./Kg. of nialamide.
RELATION BETWEEN THE PROLONGATION IN PROTHROMBIN TIME AND ANTI-THROMBOTIC EFFECTS
All animals treated by nialamide alone exhibited no prolongation of the prothrombin time ( fig. 4 ). The value was prolonged in animals treated by anticoagulants, and the value measured immediately before the challenge and at the end of the experiment showed little difference except for a few exceptional cases. Among 29 animals treated by phenindione alone, four animals exhibited a slight or moderate prolongation of prothrombin time of less than 17 seconds and a reduction in the prothrombin activity of over 15 per cent immediately before the challenge. However, the majority remained within the so-called therapeutic range for the prothrombin time of from 17 to 14 seconds and of the activity from 15 to 30 per cent. In these animals, no preventive effect was found for phenindione against thrombosis. The remaining 25 animals exhibited a more prolonged prothrombin time Relation of prothrombin activity and appearance of vascular thrombi in nialamide, phenindione, and phenindione-nialamide groups. Prothrombin activity in per cent (P.A.). 
P.A. : Prothrombin Activity in %
FIGURE 5
Comparison of vascular thrombi of vessels of nonsympa<thectomizcd side and sympathectomized side in control and nialamide groups.
of over 17 seconds and a greater reduction in the prothrombin activity to less than 15 per cent. In 20 animals, the activity ranged from 15 per cent to 6 per cent. In five animals, the prothrornbin time was markedly prolonged, ranging from over 60 seconds to infinity, and the prothrombin activity was less than 6 per cent. The preventive effect of phenindione against thrombosis in these two groups of animals was significant, but between the last two groups no significant difference was found ( fig. 4) . Moreover, the incidence ol: thrombosis in these animals showing a prothrombin activity of less than Transection of the right retroauricular artery of animal no. 120 treated by nialamide (5 mg./Kg.) Platelets are seen on the severely damaged vessel wall. However, the number of platelets is much smaller as compared 'with the animals of the control or phenindione groups. Moreover, the platelets (P 9 ) do not adhere to the vessel wall and do not aggregate each other, but remain almost naturally scattered (hematoxylin-eosin stain, X 400).
6 per cent immediately before the challenge was significantly higher than that in the animals treated with 3 to 5 mg./Kg. of nialamide and showing no prolongation of prothrombin time. Here the superiority in the antithrombotic effect of nialamide over phenindione and the entirely different kind of action of nialamide are noticeable. Results similar to those observed with the phenindione-treated group were also obtained in animals receiving warfarin, as shown in figure 1 .
In animals treated by the combination of nialamide and phenindione in effective dosage, the appearance of thrombosis does not seem to be influenced to any appreciable degree by the prolongation in the prothrombin time ( fig. 4 ). Here again, the potency of the antithrombotic effect of nialamide was evidenced. The reduction of prothrombin activity of below 30 per cent, especially of below 6 per cent, was found to be significant in the prevention of occlusive thrombosis only in animals treated by the subthreshold dose of both nialamide and phenindione in combination ( fig. 2 ).
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FIGURE 7 (A) Occlusive thrombosis produced in the marginal vein of control rabbit no. 49 stained by hematoxylin and eosin (X 90). Numerous platelets (P) aggregate and adhere to the damaged vessel wall forming the bwais of the thrombus contributing to keep clotting factors locally and to produce the fibrin. (B) The same thrombus stained by van CHeson (X 90). The fibrin (F) is clearly shown. The dense fibrin-threads (F) are seen in the basis and their branches net numerous erythrocytes (E) and occlude the vessel lumen.
INFLUENCE OF EXTIRPATION OF SUPERIOR CERVICAL GANGLION
In animals in which the superior cervical ganglion was extirpated on one side, the appearance of thrombosis was almost the same in the arteries and veins of both ears. This was observed not only in the control but also in the nialamide group ( fig. 5 ), although the vasodilatation of the ear of the sympathectomized side was apparent. The appearance of ocelnsrve thrombosis in the nialamide group is prevented in a way similar to that in the animals treated with the same amount of nialamide without the extirpation of the superior cervical ganglion. This data prove that the remarkable vasodilatation induced by sympathectomy does not significantly alter the appearance of thrombosis nor the antithrombotic effect of nialamide.
INFLUENCE OF DENERVATION OF BLOOD VESSELS
In the denervated arteries, as well as veins of the eight series of experiments, pretreatment with 5 mg./Kg. of nialamide was also shown to reduce the appearance of oeclusive thrombosis as well as grossly visible thrombosis as compared with each artery and vein of control animals ( fig. 3) . The incidence of ocelusive as well as grossly visible thrombosis was smaller in the nialamide group as compared with the group without nialamide. The difference was greater in the vein and it was statistically significant (P < 0.03).
HISTOLOGICAL FINDINGS
In the histological observations, the formation of white thrombi was almost completely prevented in the nialamide and the nialamidephenindione groups treated successfully with 3 to 5 mg./Kg. of nialamide. In a few of these animals, an accumulation of a few platelets was observed on the damaged vessel wall. Even in these instances, the aggregation of platelets was markedly prevented and platelets were scattered as if in the normal blood ( fig. 6 ). The animals treated unsuccessfully by nialamide or nialamide plus phenindione showed also the formation of white thrombi. However, even in such cases the scattering of accumulated platelets was often observed in the vicinity of the thrombi on the severely injured area of endothelium of the blood vessels, and such a scattering of platelets was not usually found in the control or phenindione group of animals. In animals treated with 1.5 mg./Kg. of nialamide, the formation of white thrombi was not prevented so markedly.
In the control and phenindione groups, the formation of white thrombi is almost the same (figs. 7 through 10). The extent of thrombosis is slightly reduced in the majority of vessels in the phenindione group as compared with the control group.
Discussion
In this experiment, nialamide, which prolongs neither the prothrombin time nor the Lee-White time, exhibited a much more potent thrombosis preventive effect than did phenindione or warfarin, both of which produce a profound prolongation of prothrombin time. In addition, the concomitant application of nialamide and phenindione in fully effective dosages, was not shown to be significantly more effective than the application of nialamide alone. The additional administration of a large amount of prothrombinopenic anticoagulant to the full dose of nialamide does not further enhance the autithrombotic effect of nialamide. Although it is believed that MAO inhibitors alter nervous function and presumably modify vasomotor tone, nialamide did not induce any appreciable vasodilatation or vasoconstriction in the ears of the test animals. The antithroinbotic effect of nialamide was not shown to be modified by sympathectomy or denervation of the blood vessels, although sympathectomy induced a A part of thrombus of control rabbit no. 19. Dense conglutination of platelets (P) on severely damaged arterial wall (hematoxylin-eosin stain, X 450). marked vasodilatation. Moreover, sympathectomy was not found to alter thrombosis in the control group of animals. Such evidences may suggest that vasomotor, as well as nervous innervation, is not involved, at least as an essential factor, in the mechanism which produces the antithrombotic effect of nialamide in this experiment.
The antithrombotic effect of nialamide may be explained by the fact that it prevents the formation of a dam of platelets and leucocytes on the injured surface of the vessel lumen. The dam prevents the washing away of the extrinsic, as well as the intrinsic clotting factors released locally. Thus, the clotting factors contained within the dam may produce fibrin from fibrinogen. Then blood corpuscles, including fine threads of erythrocytes, are caught in the fibrin and the formation of a thrombus results. In the animals treated with an effective dose of nialamide, the formation of this dam and the development of white thrombi were prevented. The aggregation of platelets was blocked ( fig. 6 ). In the other series of the authors' experiment, nialamide and iproniazid prevented the clumping of platelets in vivo in rabbits induced by the intravenous injection of dextran, glycogen, or bacterial polysaccharides. The prevention of the aggregation and dis-656 SHIMAMOTO, ISHIOKA, FTJJITA integration of platelets which contain potent clotting and antifibrinolytic factors 7 ' s may also be involved in the antithrombotic effect of nialamide.
Nialamide was also found to inhibit the release of eateeholamines in patients suffering from pheochromocytoma (unpublished observations). The release of epinephrine from the adrenal medulla by chemical substances are also found to be inhibited in dogs by Gatgouns and Aycock. 0 On the other hand, epinephrine was discovered to be specifically effective in inducing the adherence of platelets to the endothelial surface. 10 For such reasons, the inhibitory effect of nialamide on the release of epinephrine may not be excluded from the mechanism involved in its antithrombotic effect and such an effect might be analyzed further. On the other hand, in the animals treated with phenindione or warfarin, the formation of white thrombi was not prevented. The closes of phenindione or warfarin used in these experiments was so large that the prothrombin time was profoundly prolonged. In the majority of cases, doses were beyond the so-called therapeutic range in their effect on the prothrombin activity when the values are translated into clinical equivalents. The prothrombinopenic anticoagulants do not completely counteract but merely reduce and retard the activity of the clotting factors. The formation of fibrin, while limited, continues to take place as long as the dam of platelets and leukocytes exists. The relative ineffectiveness of these anticoagulants, as compared to nialamide, may be explained by this reason. Thus, the superiority in the effect produced by a new type of antithrombotic substance over the prothrombinopenic anticoagulants in this experiment may be understandable. The results obtained in this experiment may show the potency of a new type of antithrombotic effect by blocking the hemostatic process played by platelets 4 ' 5 and leukocytes without interfering with the phylogenetieally young hemostatic process played by the fibrinogen-fibrin system directly.
The effective dose of nialamide (3 mg./Kg.) seems to be the minimal threshold dose in rabbits; 5 mg./Kg. was shown to be more effective than 3 mg./Kg., while 1.5 mg./Kg. is a subthreshold dose and is almost ineffective. However, the combination of nialamide and phenindione in subthreshold dosages was shown to be significantly effective. The synergistic effect of two drugs may also suggest a possibly useful method for clinical application.
Summary
A new type of antithrombotic substauee, nialamide, was compared witli phenindione and warfarin in its preventive effect against experimental thrombosis produced in rabbits. One hundred fifty-seven rabbits were subjected to quantitative traumatization of the endothelial surface of the retroauricular artery and marginal vein of the ear. Pretreatment of animals with 3 to 5 mg./Kg. of nialamide, which did not prolong the one-stage prothrombin time, was much more effective in preventing thrombosis than either phenindione or warfarin, both of which prolonged the prothrombin time markedly. Even in the Circulation Research, Volume X, April 19GS animals pretreated by 600 to 900 mg. of pheuindione, which reduced the prothrombin activity to less than 6 per cent, the preventive effect of phenindione is significantly less than the antithrombotic effect of 3 to 5 mg./Kg. of nialamide. Pretreatment of animals with 1.5 mg./Kg. of nialamide was found to be ineffective. However, the concomitant application of subeffective doses of both phenindione, 150 ing., and nialamide, 1.5 mg., was found to be effective. On the other hand, the addition of phenindione, even in doses as large as 300 to !)00 mg., to an effective dose of nialamide, 3 to 5 mg./Kg., did not further enhance the antithrombotic effect of nialamide. The antithrombotic effect of nialamide was not shown to be significantly modified by sympathectomy or by denervation of the blood vessels tested. Nialamide was found to prevent the aggregation of platelets on the injured endothelial surface.
